Nano-Assembly of Pamitoyl-Bioconjugated Coenzyme-A for Combinatorial Chemo-Biologics in Transcriptional Therapy

Bioconjugate Chemistry
Santosh K MisraDipanjan Pan

Abstract

Pathogenesis, the biological mechanism that leads to the diseased state, of many cancers is driven by interruptions to the role of Myc oncoprotein, a regulator protein that codes for a transcription factor. One of the most significant biological interruptions to Myc protein is noted as its dimerization with Max protein, another important factor of family of transcription factors. Binding of this heterodimer to E-Boxes, enhancer boxes as DNA response element found in some eukaryotes that act as a protein-binding site and have been found to regulate gene expression, are interrupted to regulate cancer pathogenesis. The systemic effectiveness of potent small molecule inhibitors of Myc-Max dimerization has been limited by poor bioavailability, rapid metabolism, and inadequate target site penetration. The potential of gene therapy for targeting Myc can be fully realized by successful synthesis of a smart cargo. We developed a "nuclein" type nanoparticle "siNozyme" (45 ± 5 nm) from nanoassembly of pamitoyl-bioconjugated acetyl coenzyme-A for stable incorporation of chemotherapeutics and biologics to achieve remarkable growth inhibition of human melanoma. Results indicated that targeting transcriptional gene cMyc with siRNA with codeli...Continue Reading

References

Feb 1, 1976·Canadian Journal of Biochemistry·S Cheema-Dhadli, M L Halperin
Oct 1, 1990·Molecular and Cellular Biology·M J SmithE V Prochownik
Feb 1, 1993·Current Opinion in Genetics & Development·G I Evan, T D Littlewood
Jan 1, 1996·Advances in Cancer Research·M Henriksson, B Lüscher
May 21, 1998·Nature Biotechnology·J A Wolff, V S Trubetskoy
Nov 20, 2001·Molecular and Cellular Biology·I CollinsD Levens
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Thorsten BergPeter K Vogt
Oct 3, 2002·Nature Reviews. Cancer·James E Darnell
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
May 29, 2003·Current Cancer Drug Targets·Heiko Hermeking
Sep 19, 2003·Oncogene·Xiaoying YinEdward V Prochownik
Apr 2, 2004·Expert Review of Anticancer Therapy·Edward V Prochownik
Sep 8, 2004·Langmuir : the ACS Journal of Surfaces and Colloids·Rahul P BagweWeihong Tan
Mar 10, 2005·The Journal of Gene Medicine·Richard W Horobin, Volkmar Weissig
Sep 21, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Qianhong LiRoberto Bolli
Jul 29, 2006·Chemistry & Biology·Anke KiesslingThorsten Berg
Aug 15, 2006·Seminars in Cancer Biology·Chi V DangFeng Li
Aug 29, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ji Sun ParkYong Woo Cho
Jan 12, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L BagnascoS Parodi
Apr 3, 2007·The Journal of Gene Medicine·Elizabeth CollinsMark Gumbleton
Aug 28, 2007·Cell·Howard Riezman
Dec 7, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xuguang ChenPamela B Davis
Oct 29, 2008·Oncogene·B Hoffman, D A Liebermann
Mar 17, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gaurav SahayAlexander V Kabanov
May 8, 2010·Expert Opinion on Drug Delivery·Erem Bilensoy
Aug 4, 2010·Current Topics in Microbiology and Immunology·Thorsten Berg
Aug 31, 2010·The Journal of Pharmacology and Experimental Therapeutics·Dana M ClausenJulie L Eiseman
Oct 6, 2010·Chemical Communications : Chem Comm·Yan ZhangOlof Ramström
May 3, 2011·Nature Reviews. Drug Discovery·Denise A Chan, Amato J Giaccia
May 4, 2011·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Adrian ChrastinaJan E Schnitzer
Jun 21, 2011·Chemical Society Reviews·Karl GruberBernhard Kräutler
Oct 1, 2011·Chemical Communications : Chem Comm·Michael E Hahn, Nathan C Gianneschi
Feb 22, 2012·Journal of the American Chemical Society·Daniel F MoyanoVincent M Rotello
Apr 10, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yechezkel Barenholz
Nov 1, 2010·Therapeutic Delivery·Himanshu BhattacharjeeGeorge C Wood
Oct 31, 2012·Journal of the American Chemical Society·Sophie R HarveyPerdita E Barran
Mar 5, 2013·Molecular Pharmaceutics·Dipanjan Pan
Oct 24, 2013·Nature Materials·Rosemary KanastyDaniel Anderson
Nov 12, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Christine T N PhamDennis E Hourcade

❮ Previous
Next ❯

Citations

Oct 28, 2019·International Journal of Molecular Sciences·Aishani WadhawanGurpal Singh
Dec 19, 2020·Biomedicines·Saffiya HabibMoganavelli Singh
Aug 29, 2019·The Journal of Organic Chemistry·Tobias BrandhoferOlga García Mancheño

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.